Yichang Ren

Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1

Binbin Cheng, Yichang Ren, Hao Cao et al. · European Journal of Medicinal Chemistry · 2020 · 110 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +8

Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities

Yichang Ren, Yuxi Wang, Gang Li et al. · Journal of Medicinal Chemistry · 2021 · 105 citations

Medicine, Medicinal Chemistry, Oncology +14

Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory Efficacy

Jin Liu, L. Yuan, Yong Ruan et al. · Journal of Medicinal Chemistry · 2022 · 95 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents

Binbin Cheng, Yichang Ren, Xiaoge Niu et al. · Journal of Medicinal Chemistry · 2020 · 82 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment

Xin Deng, Ruiyao Mai, Chen‐Yu Zhang et al. · European Journal of Medicinal Chemistry · 2020 · 69 citations

Pharmacy, Oncology, Pharmaceutics +16